Specify a stock or a cryptocurrency in the search bar to get a summary
WuXi XDC Cayman Inc
2268WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. It also provides international sales contracting services. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc. Address: No. 11 Xinhui Ring Road, Wuxi, China
Analytics
WallStreet Target Price
246.96 HKDP/E ratio
45.8333Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 2268
Dividend Analytics 2268
Dividend growth over 5 years
–Continuous growth
2 yearsPayout Ratio 5 years average
–Dividend History 2268
Stock Valuation 2268
Financials 2268
Results | 2019 | Dynamics |